Skyways Air vs Symbiotec vs Hy-Tech: Analysts pick their top IPO bet
Symbiotec Pharmalab stands out as the preferred long-term pick, backed by SBI Securities' 'Subscribe' rating and Master Capital's positive view on its specialised business.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
